Four years ago, Taylor Brown received a bone marrow transplant at the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta as treatment for severe aplastic anemia.
In 1999, with the country ravaged by HIV and its future existence literally in doubt, Botswana embarked on an aggressive plan to curtail the transmission of the virus from mother to child.
The Dr. Martin Luther King, Jr. holiday marks a National Day of Service and an important time of reflection. In 1966 Rev. Dr. Martin Luther King, Jr. spoke at the National Convention of the Medical Committee for Human Rights
Northern Trust is helping to fund a $4.75 million comprehensive home-based asthma program, known as the New York Healthy Homes Collaborative, to improve quality of life for 850 New York City children and adults on Medicaid.
As a middle school math teacher in Woodbridge, Virginia, Dr. Arik King saw firsthand how boys of color trailed their peers in test scores, attendance, and graduation rates—part of an alarming and persistent national trend.
Illumina Inc. (NASDAQ: ILMN) today announced a partnership with Boehringer Ingelheim to develop companion diagnostics (CDx) for several programs in Boehringer Ingelheim's oncology pipeline. The partnership aims to accelerate the development of therapy selection and precision medicines for patients with advanced cancer.
Illumina, Inc. (NASDAQ: ILMN) today announced a multi-year partnership with Agendia N.V., a world leader in precision oncology for breast cancer, to co-develop in vitro diagnostic (IVD) tests for oncology testing. The partnership is intended to advance the use of next-generation sequencing (NGS) for decentralized oncology testing and aligns with Illumina's approach to IVD partnerships in oncology. Agendia joins Illumina's growing portfolio of more than 30 IVD partners developing over 40 sequencing-based solutions for cancer prognosis, therapy selection and other applications.
Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinico-genomic resource. Using Illumina's next-generation sequencing (NGS) platforms, scientists and researchers will be able to better identify disease associations and targets for intervention by analyzing data derived from VUMC's extensive, high-quality biobank of approximately 250,000 de-identified human DNA samples and associated longitudinal, structured medical data.
Illumina, Inc. (NASDAQ:ILMN) Chief Executive Officer, Francis deSouza, discussed the company's strong growth trajectory, including 2021 results and 2022 guidance. deSouza also announced new partnerships and technologies that will advance the company's mission of improving human health by unlocking the power of the genome.
In celebration of National Blood Donor Month AEG’s LA Kings and the Kings Care Foundation recently kicked off its blood drive series in conjunction with Children’s Hospital Los Angeles (CHLA) at Crypto.com Arena (formerly STAPLES Center).
AEG embraces its responsibility to enrich the lives of people in the communities around the world where we do business, and to use business to create...
More than ever, retaining and recruiting employees is a top priority for companies. Aware of the link between workplace giving and employee engagement...
AEG embraces its responsibility to enrich the lives of people in the communities around the world where we do business, and to use business to create...
Trane Technologies is a global climate innovator with a clear purpose to boldly challenge what’s possible for a sustainable world. See how embedding...
